Pay in 4 interest-free payments of $5.81 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Implications for pharma marketers and consumers: As Lilly and Novo continue to expand their anti-obesity pipelines, theyre also navigating commercial and marketing shifts
Pochini L, Scalise M, Galluccio M, Indiveri C
Semaglutide 2.4 mg (Wegovy) is approved under NICE technology appraisal TA875, and tirzepatide (Mounjaro) has also received a NICE technology appraisal for weight management
The 48-hour rule covers all weekly semaglutide injections the standard 2.4 mg Wegovy, the new Wegovy HD 7.2 mg, and all Ozempic doses
US$ 26.87
US$ 26.00
US$ 27.01
US$ 21.87
US$ 22.13
US$ 21.96
